CLINDAMYCIN INJECTI

The contract involves the procurement of Clindamycin Injectable, identified by the National Stock Number 6505-01-177-1982, with a purchase request quantity of one unit. The solicitation, numbered SPE2DP-26-T-3732, was posted on June 8, 2026, and responses were due by June 15, 2026. This solicitation is issued by the Defense Logistics Agency under the Department of Defense, indicating federal government involvement and likely military use. The contract is part of a formal solicitation process with no specified set-aside status or NAICS code, suggesting it may be open to a broad range of suppliers without preference for small or disadvantaged businesses. Although detailed location information for the office or place of performance is not provided, the contract is linked to a government procurement website for official documentation and bid submission. Overall, this contract reflects a routine acquisition of a pharmaceutical product essential for medical applications within the Department of Defense.